data_2vik_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2vik _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 21.9 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.482 -0.562 . . . . 2.1299999999999999 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 14.6 pt-20 40.2 75.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.484 -0.76 . . . . 2.8100000000000001 109.804 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' HD21 ' A' ' 3' ' ' LEU . 2.5 pt? -47.2 -36.8 9.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 2.3300000000000001 109.561 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 1.7 p -43.34 151.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 2.1699999999999999 109.661 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 1.5 tttt 80.07 -72.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 2.8999999999999999 109.75 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' C ' HG21 ' A' ' 7' ' ' VAL . 17.3 mmtt -86.76 17.06 4.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.075 -1.016 . . . . 4.4500000000000002 109.638 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.514 HG12 ' CZ2' ' A' ' 21' ' ' TRP . 11.9 t -151.51 -72.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 1.46 109.485 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.5 ' HB ' ' CD2' ' A' ' 87' ' ' TYR . 74.6 p -48.92 -23.24 1.04 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 2.3999999999999999 109.462 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -57.28 -54.41 37.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 2.5099999999999998 109.555 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 4.0 mtmt -145.54 62.71 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 3.6299999999999999 109.455 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.511 ' CD2' HG11 ' A' ' 7' ' ' VAL . 11.2 mt -46.81 -61.49 1.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 2.25 109.495 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -158.67 126.1 4.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 3.5099999999999998 109.479 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' O ' ' OG1' ' A' ' 14' ' ' THR . 11.3 mttt -140.74 132.25 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 2.3300000000000001 109.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 38.2 p 48.89 57.8 6.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.422 -0.799 . . . . 3.54 109.562 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 14' ' ' THR . 16.4 m -170.02 105.78 0.44 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.466 -0.771 . . . . 2.3399999999999999 109.325 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 117.65 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.367 2.045 . . . . 1.22 110.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 170.02 -142.95 7.54 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.143 -1.583 . . . . 0.71999999999999997 109.143 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 110' ' ' PHE . 14.6 pt -157.27 141.83 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -1.205 . . . . 1.76 110.115 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.573 ' O ' ' CZ3' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -121.51 111.17 16.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.854 -1.165 . . . . 2.7000000000000002 107.854 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mt -88.87 177.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.941 -1.1 . . . . 1.1100000000000001 110.052 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.574 ' CG ' ' HE3' ' A' ' 28' ' ' MET . 10.7 m-90 -137.84 117.93 13.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.151 -1.426 . . . . 0.44 107.151 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.529 ' CD ' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -78.47 134.78 37.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.143 -0.973 . . . . 2.75 110.185 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.521 HG13 ' CB ' ' A' ' 44' ' ' CYS . 10.9 mm -105.1 31.31 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.427 -0.953 . . . . 1.72 108.427 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 2.4 pt-20 -57.44 166.01 1.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.526 -0.734 . . . . 2.6299999999999999 109.879 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' HB2' ' CB ' ' A' ' 122' ' ' ALA . 14.4 p30 42.32 27.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.473 -0.767 . . . . 2.73 109.413 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.52 ' O ' ' CG ' ' A' ' 27' ' ' GLU . 28.7 mmm 58.06 53.91 6.36 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.325 -0.859 . . . . 2.23 109.858 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 26' ' ' MET . 53.0 mt-10 -159.46 132.82 7.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 2.23 109.386 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -66.26 148.15 52.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 1.8300000000000001 109.788 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 21' ' ' TRP . 2.2 t -153.93 146.62 17.61 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.038 -1.097 . . . . 0.96999999999999997 108.038 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HD2' HG12 ' A' ' 29' ' ' VAL . 31.5 Cg_endo -72.15 111.57 3.22 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.357 2.038 . . . . 0.87 112.03 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.495 HG21 ' CD ' ' A' ' 22' ' ' ARG . 38.8 t -106.47 99.34 23.89 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.822 -0.807 . . . . 0.80000000000000004 108.822 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.3 Cg_endo -77.6 -159.57 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.501 2.134 . . . . 0.67000000000000004 110.452 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -85.02 -8.73 58.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 1.25 109.104 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -74.2 -19.26 60.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.285 -0.884 . . . . 3.5499999999999998 109.616 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -131.12 -5.59 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 1.6599999999999999 110.185 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.2 OUTLIER -55.47 134.19 50.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 1.8100000000000001 109.43 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA2' HD21 ' A' ' 114' ' ' LEU . . . 118.85 -69.88 0.33 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 1.3 109.414 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -83.17 83.7 7.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -1.163 . . . . 1.98 109.275 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -114.29 133.32 55.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 2.3500000000000001 109.514 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 26.8 m-85 -39.21 147.85 0.06 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.563 -0.71 . . . . 2.4399999999999999 110.15 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 20.1 pt-20 -90.33 -41.99 11.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.378 -0.826 . . . . 1.8500000000000001 109.947 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.587 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -84.07 65.23 4.14 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 110.019 -1.232 . . . . 1.1399999999999999 110.019 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -163.1 -145.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.052 -1.264 . . . . 1.3500000000000001 110.374 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.521 ' CB ' HG13 ' A' ' 23' ' ' ILE . 7.4 m -142.03 146.32 35.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.247 -1.02 . . . . 0.87 108.247 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.9 m-85 -144.63 109.9 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.941 -1.099 . . . . 2.1899999999999999 110.285 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 95.5 t -79.99 123.7 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.55000000000000004 108.546 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 18' ' ' ILE . 7.1 tt -112.15 118.44 35.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.93000000000000005 110.347 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' CD2' ' HB3' ' A' ' 11' ' ' LEU . 24.6 tp -102.81 106.76 17.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.85999999999999999 109.616 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -94.58 137.9 33.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.54000000000000004 109.671 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -131.22 132.13 44.45 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.613 -0.679 . . . . 0.93000000000000005 109.26 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 35.8 ttm180 -125.43 160.03 30.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 3.1800000000000002 109.458 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.522 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 10.6 pttm -85.17 153.6 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.73 109.502 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -147.72 178.33 8.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.94999999999999996 109.504 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.04 -17.55 74.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.516 -1.434 . . . . 1.1499999999999999 109.516 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -98.66 -31.8 11.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -1.138 . . . . 1.71 109.502 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.38 -103.84 0.19 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.553 -1.419 . . . . 0.93999999999999995 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 34.1 m-85 -141.4 153.44 45.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 2.3900000000000001 109.521 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -117.42 109.66 17.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 1.3100000000000001 108.915 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 32.4 m-85 -87.38 157.9 19.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 2.1200000000000001 110.038 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.0 m-20 -148.29 91.18 1.88 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.376 -0.972 . . . . 1.52 108.376 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 81' ' ' THR . 15.4 mt -78.17 135.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.81000000000000005 110.245 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 48.6 m-70 -121.02 159.39 25.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.164 -0.68 . . . . 0.33000000000000002 109.164 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 51.1 p90 -132.51 97.56 4.12 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.147 -1.421 . . . . 2.1499999999999999 109.422 176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.9 t90 -76.99 132.86 39.22 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.879 -0.785 . . . . 0.52000000000000002 108.879 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -120.53 65.43 0.84 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.368 -0.832 . . . . 1.26 110.976 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -50.52 90.28 0.01 OUTLIER Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.215 -1.954 . . . . 0.39000000000000001 108.215 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -38.74 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.094 0.95 . . . . 2.71 112.363 -177.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.6 m120 -162.76 -46.11 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.75 -0.833 . . . . 1.8899999999999999 108.75 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 73' ' ' GLU . 80.8 p -60.87 -158.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.539 -0.726 . . . . 0.89000000000000001 109.353 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.92 166.7 10.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 109.609 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.98 -45.93 32.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 2.9100000000000001 109.39 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.06 -41.1 74.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 1.4099999999999999 109.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG2' ' CB ' ' A' ' 69' ' ' SER . 13.0 tp10 -55.28 -40.86 71.52 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.275 -1.009 . . . . 2.3700000000000001 108.275 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.524 ' CG ' HD13 ' A' ' 65' ' ' LEU . 4.9 tt0 -59.54 -36.52 76.3 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.979 -1.119 . . . . 2.3500000000000001 107.979 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . -70.83 -25.5 75.65 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.005 -1.638 . . . . 0.47999999999999998 109.005 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -74.89 -66.0 0.8 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -1.115 . . . . 0.71999999999999997 109.326 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.11 -37.27 6.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.64000000000000001 109.359 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.58 -38.19 67.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.48999999999999999 109.588 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' GLY . 16.1 mt -61.19 -50.33 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 2.0699999999999998 109.553 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 92.5 m-85 -57.37 -44.22 84.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.069 -1.019 . . . . 2.3300000000000001 108.915 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.549 ' CG2' ' CG2' ' A' ' 61' ' ' ILE . 3.6 m -64.36 -24.9 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.92000000000000004 108.677 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -83.98 -20.39 32.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.542 -0.724 . . . . 0.79000000000000004 109.254 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.516 ' CB ' HD22 ' A' ' 3' ' ' LEU . 10.3 mt-30 -84.95 -32.29 23.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.9299999999999999 109.527 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.558 ' HE2' ' CZ3' ' A' ' 21' ' ' TRP . 14.6 ptp -86.89 -18.72 30.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 1.8600000000000001 109.394 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 25.9 t0 -67.89 -40.06 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.875 . . . . 1.3200000000000001 109.372 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -89.92 -37.17 14.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 2.21 109.421 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.5 ' CD2' ' HB ' ' A' ' 8' ' ' THR . 6.2 m-85 -67.18 -17.26 64.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.875 . . . . 2.3700000000000001 109.45 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 11' ' ' LEU . 15.4 mt -81.38 -24.16 37.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.85999999999999999 109.492 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 123.93 7.68 6.51 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.653 -1.379 . . . . 0.89000000000000001 109.653 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 76.06 -0.69 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -1.154 . . . . 2.4399999999999999 109.646 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.469 HG22 ' CE1' ' A' ' 59' ' ' TYR . 27.4 m -83.67 -12.78 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 1.53 109.331 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -78.09 173.54 12.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.51000000000000001 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.526 ' CG2' ' OD1' ' A' ' 60' ' ' ASN . 3.8 t -128.41 176.52 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.388 -0.82 . . . . 0.5 109.139 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -123.88 133.25 53.79 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.022 -1.049 . . . . 2.1600000000000001 109.219 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 23.0 m-70 -128.41 152.22 48.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.37 109.508 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 43.7 ttt180 -110.22 131.69 54.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.9900000000000002 110.354 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 29.2 mm-40 -141.92 163.93 31.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 2.0099999999999998 109.42 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.517 ' N ' ' HB2' ' A' ' 101' ' ' HIS . 2.2 t -154.74 -164.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.69999999999999996 108.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 67' ' ' LYS . 15.3 pt20 -75.95 2.65 12.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.736 -1.227 . . . . 2.8399999999999999 109.965 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.12 19.96 0.96 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.252 -1.939 . . . . 0.95999999999999996 108.252 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.517 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.7 m-70 -122.06 -19.47 6.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.658 -0.907 . . . . 1.3400000000000001 109.486 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.585 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.21 24.36 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 2.77 109.168 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.0 p -47.63 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.834 . . . . 1.8100000000000001 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 20.7 mt-10 -68.15 -17.48 64.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.98 -1.075 . . . . 2.2400000000000002 111.276 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.492 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.8 m -72.85 -55.31 6.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.817 -1.177 . . . . 0.73999999999999999 109.628 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.02 -56.03 20.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.26 -1.015 . . . . 2.1699999999999999 108.26 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.7 ttp85 -57.98 -29.63 65.4 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.312 -0.867 . . . . 2.48 108.79 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 104' ' ' GLU . . . -53.32 -53.39 51.64 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.171 -1.048 . . . . 0.84999999999999998 108.171 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.75 -23.48 67.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.643 -0.873 . . . . 2.02 108.643 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 18' ' ' ILE . 14.8 m-85 -107.59 94.94 5.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 2.29 109.463 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -82.42 71.41 9.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 3.0099999999999998 109.301 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -173.9 -77.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 4.0099999999999998 109.526 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.57 129.07 1.38 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.462 -1.455 . . . . 2.0299999999999998 109.462 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.585 ' CD2' ' CG ' ' A' ' 110' ' ' PHE . 76.0 mt -97.09 119.08 34.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 1.72 109.766 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.5 mt -88.28 166.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.96999999999999997 108.855 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.575 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -142.43 103.41 4.25 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.294 -0.879 . . . . 2.2599999999999998 109.426 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 22.7 mmtt -79.97 -169.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 2.0699999999999998 109.574 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.575 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -90.64 133.59 35.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 2.8599999999999999 109.733 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.38 -159.48 0.52 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.743 -1.343 . . . . 1.0900000000000001 109.743 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.14 65.73 2.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.511 -1.436 . . . . 1.53 109.511 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.488 ' CG2' ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -90.19 -1.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -1.164 . . . . 2.3500000000000001 110.111 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 25' ' ' ASN . . . -90.65 4.95 49.97 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.73 -0.606 . . . . 4.0499999999999998 109.737 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -67.31 -73.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 5.2999999999999998 109.323 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 125' ' ' MET . . . 41.94 27.23 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.694 -1.362 . . . . 5.2000000000000002 109.694 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 126' ' ' LYS . 7.9 mmt -156.07 -69.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -1.149 . . . . 8.0399999999999991 109.347 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 125' ' ' MET . 9.4 mmtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.029 -0.986 . . . . 10.48 109.463 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 21.9 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.482 -0.562 . . . . 1.65 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 14.6 pt-20 40.2 75.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.484 -0.76 . . . . 2.81 109.804 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.599 HD21 ' CB ' ' A' ' 83' ' ' GLN . 2.5 pt? -47.2 -36.8 9.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 1.75 109.561 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.525 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.7 p -43.34 151.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 1.89 109.661 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 1.5 tttt 80.07 -72.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 2.54 109.75 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -86.76 17.06 4.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.075 -1.016 . . . . 4.04 109.638 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG12 ' CD2' ' A' ' 11' ' ' LEU . 11.9 t -151.51 -72.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 1.05 109.485 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.507 ' HB ' ' CD2' ' A' ' 87' ' ' TYR . 74.6 p -48.92 -23.24 1.04 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 1.93 109.462 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -57.28 -54.41 37.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 2.51 109.555 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 4.0 mtmt -145.54 62.71 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 3.24 109.455 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.853 ' CD2' HG12 ' A' ' 7' ' ' VAL . 11.2 mt -46.81 -61.49 1.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 1.65 109.495 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -158.67 126.1 4.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 3.51 109.479 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 12' ' ' ASP . 11.3 mttt -140.74 132.25 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 2.16 109.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 38.2 p 48.89 57.8 6.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.422 -0.799 . . . . 3.15 109.562 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.4 m -170.02 105.78 0.44 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.466 -0.771 . . . . 2.28 109.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 117.65 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.367 2.045 . . . . 1.08 110.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 18' ' ' ILE . . . 170.02 -142.95 7.54 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.143 -1.583 . . . . 0.72 109.143 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.975 HD12 HD11 ' A' ' 47' ' ' LEU . 14.6 pt -157.27 141.83 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -1.205 . . . . 0.98 110.115 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.715 ' NE2' ' CZ2' ' A' ' 21' ' ' TRP . 4.6 tt0 -121.51 111.17 16.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.854 -1.165 . . . . 2.7 107.854 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.898 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mt -88.87 177.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.941 -1.1 . . . . 0.61 110.052 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.715 ' CZ2' ' NE2' ' A' ' 19' ' ' GLN . 10.7 m-90 -137.84 117.93 13.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.151 -1.426 . . . . 0.36 107.151 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.676 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -78.47 134.78 37.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.143 -0.973 . . . . 2.33 110.185 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.707 HD13 ' HA ' ' A' ' 28' ' ' MET . 10.9 mm -105.1 31.31 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.427 -0.953 . . . . 0.89 108.427 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HB2' HG12 ' A' ' 121' ' ' VAL . 2.4 pt-20 -57.44 166.01 1.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.526 -0.734 . . . . 2.63 109.879 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.85 ' CB ' ' HB2' ' A' ' 122' ' ' ALA . 14.4 p30 42.32 27.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.473 -0.767 . . . . 2.29 109.413 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.571 ' HE3' ' OE1' ' A' ' 73' ' ' GLU . 28.7 mmm 58.06 53.91 6.36 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.325 -0.859 . . . . 1.85 109.858 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 26' ' ' MET . 53.0 mt-10 -159.46 132.82 7.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 2.23 109.386 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.707 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -66.26 148.15 52.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 1.23 109.788 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG13 ' HD2' ' A' ' 30' ' ' PRO . 2.2 t -153.93 146.62 17.61 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.038 -1.097 . . . . 0.48 108.038 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HD2' HG13 ' A' ' 29' ' ' VAL . 31.5 Cg_endo -72.15 111.57 3.22 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.357 2.038 . . . . 0.87 112.03 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.676 HG23 ' H ' ' A' ' 22' ' ' ARG . 38.8 t -106.47 99.34 23.89 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.822 -0.807 . . . . 0.48 108.822 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.3 Cg_endo -77.6 -159.57 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.501 2.134 . . . . 0.61 110.452 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -85.02 -8.73 58.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 1.21 109.104 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -74.2 -19.26 60.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.285 -0.884 . . . . 3.05 109.616 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -131.12 -5.59 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 1.4 110.185 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.2 OUTLIER -55.47 134.19 50.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 1.66 109.43 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 118.85 -69.88 0.33 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 1.04 109.414 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -83.17 83.7 7.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -1.163 . . . . 1.32 109.275 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.659 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -114.29 133.32 55.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 1.46 109.514 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 26.8 m-85 -39.21 147.85 0.06 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.563 -0.71 . . . . 1.55 110.15 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 20.1 pt-20 -90.33 -41.99 11.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.378 -0.826 . . . . 1.85 109.947 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.621 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -84.07 65.23 4.14 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 110.019 -1.232 . . . . 0.6 110.019 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -163.1 -145.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.052 -1.264 . . . . 1.35 110.374 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.525 ' CB ' HG13 ' A' ' 23' ' ' ILE . 7.4 m -142.03 146.32 35.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.247 -1.02 . . . . 0.37 108.247 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.9 m-85 -144.63 109.9 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.941 -1.099 . . . . 1.28 110.285 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG13 ' OG1' ' A' ' 81' ' ' THR . 95.5 t -79.99 123.7 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.38 108.546 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.975 HD11 HD12 ' A' ' 18' ' ' ILE . 7.1 tt -112.15 118.44 35.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.75 110.347 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 59' ' ' TYR . 24.6 tp -102.81 106.76 17.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.45 109.616 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -94.58 137.9 33.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.39 109.671 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -131.22 132.13 44.45 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.613 -0.679 . . . . 0.52 109.26 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 35.8 ttm180 -125.43 160.03 30.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 2.73 109.458 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 10.6 pttm -85.17 153.6 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.2 109.502 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -147.72 178.33 8.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.95 109.504 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.04 -17.55 74.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.516 -1.434 . . . . 1.06 109.516 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -98.66 -31.8 11.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -1.138 . . . . 1.39 109.502 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.38 -103.84 0.19 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.553 -1.419 . . . . 0.94 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 34.1 m-85 -141.4 153.44 45.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 1.56 109.521 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -117.42 109.66 17.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 1.06 108.915 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.699 ' HD1' HG23 ' A' ' 91' ' ' VAL . 32.4 m-85 -87.38 157.9 19.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 1.27 110.038 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.0 m-20 -148.29 91.18 1.88 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.376 -0.972 . . . . 0.94 108.376 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 1.005 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.4 mt -78.17 135.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.32 110.245 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.741 ' CD2' ' HB2' ' A' ' 95' ' ' HIS . 65.0 m80 -121.02 159.39 25.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.164 -0.68 . . . . 0.27 109.164 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 51.1 p90 -132.51 97.56 4.12 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.147 -1.421 . . . . 1.31 109.422 176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.609 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.9 t90 -76.99 132.86 39.22 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.879 -0.785 . . . . 0.47 108.879 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -120.53 65.43 0.84 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.368 -0.832 . . . . 0.7 110.976 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -50.52 90.28 0.01 OUTLIER Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.215 -1.954 . . . . 0.33 108.215 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -38.74 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.094 0.95 . . . . 2.25 112.363 -177.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.621 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.6 m120 -162.76 -46.11 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.75 -0.833 . . . . 1.52 108.75 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 73' ' ' GLU . 80.8 p -60.87 -158.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.539 -0.726 . . . . 0.71 109.353 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.441 ' H ' ' HE1' ' A' ' 26' ' ' MET . 0.1 OUTLIER -111.92 166.7 10.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.95 109.609 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.98 -45.93 32.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 2.57 109.39 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.06 -41.1 74.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 1.41 109.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE1' ' HE3' ' A' ' 26' ' ' MET . 13.0 tp10 -55.28 -40.86 71.52 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.275 -1.009 . . . . 2.37 108.275 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.435 ' HG3' HD11 ' A' ' 65' ' ' LEU . 25.0 tt0 -59.54 -36.52 76.3 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.979 -1.119 . . . . 2.35 107.979 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -70.83 -25.5 75.65 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.005 -1.638 . . . . 0.47 109.005 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -74.89 -66.0 0.8 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -1.115 . . . . 0.47 109.326 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -46.11 -37.27 6.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.36 109.359 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.58 -38.19 67.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.4 109.588 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 75' ' ' GLY . 16.1 mt -61.19 -50.33 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 1.4 109.553 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 92.5 m-85 -57.37 -44.22 84.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.069 -1.019 . . . . 1.48 108.915 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.005 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.6 m -64.36 -24.9 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.4 108.677 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -83.98 -20.39 32.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.542 -0.724 . . . . 0.47 109.254 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.599 ' CB ' HD21 ' A' ' 3' ' ' LEU . 10.3 mt-30 -84.95 -32.29 23.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.75 109.527 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.79 ' HG3' HD13 ' A' ' 61' ' ' ILE . 14.6 ptp -86.89 -18.72 30.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 1.23 109.394 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.568 ' HA ' HD11 ' A' ' 61' ' ' ILE . 25.9 t0 -67.89 -40.06 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.875 . . . . 1.32 109.372 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -89.92 -37.17 14.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 2.21 109.421 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.507 ' CD2' ' HB ' ' A' ' 8' ' ' THR . 6.2 m-85 -67.18 -17.26 64.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.875 . . . . 1.67 109.45 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' CD1' ' A' ' 11' ' ' LEU . 15.4 mt -81.38 -24.16 37.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.83 109.492 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 123.93 7.68 6.51 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.653 -1.379 . . . . 0.66 109.653 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 76.06 -0.69 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -1.154 . . . . 2.25 109.646 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.699 HG23 ' HD1' ' A' ' 59' ' ' TYR . 27.4 m -83.67 -12.78 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 1.28 109.331 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -78.09 173.54 12.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.4 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.8 t -128.41 176.52 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.388 -0.82 . . . . 0.36 109.139 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.674 ' H ' HG12 ' A' ' 93' ' ' VAL . 14.5 tt0 -123.88 133.25 53.79 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.022 -1.049 . . . . 2.16 109.219 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.741 ' HB2' ' CD2' ' A' ' 62' ' ' HIS . 23.0 m-70 -128.41 152.22 48.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.27 109.508 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 43.7 ttt180 -110.22 131.69 54.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.43 110.354 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 29.2 mm-40 -141.92 163.93 31.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 2.01 109.42 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -154.74 -164.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.45 108.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.752 ' H ' HG12 ' A' ' 98' ' ' VAL . 15.3 pt20 -75.95 2.65 12.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.736 -1.227 . . . . 2.34 109.965 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.12 19.96 0.96 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.252 -1.939 . . . . 0.73 108.252 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.542 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.7 m-70 -122.06 -19.47 6.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.658 -0.907 . . . . 0.99 109.486 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.21 24.36 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 2.77 109.168 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.0 p -47.63 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.834 . . . . 1.45 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.871 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 20.7 mt-10 -68.15 -17.48 64.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.98 -1.075 . . . . 2.24 111.276 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m -72.85 -55.31 6.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.817 -1.177 . . . . 0.63 109.628 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.554 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.02 -56.03 20.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.26 -1.015 . . . . 1.25 108.26 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.7 ttp85 -57.98 -29.63 65.4 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.312 -0.867 . . . . 1.95 108.79 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -53.32 -53.39 51.64 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.171 -1.048 . . . . 0.69 108.171 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.579 ' HB3' HD13 ' A' ' 18' ' ' ILE . 28.1 m-85 -64.75 -23.48 67.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.643 -0.873 . . . . 1.21 108.643 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 1.079 ' CG ' HD21 ' A' ' 114' ' ' LEU . 14.8 m-85 -107.59 94.94 5.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 1.4 109.463 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -82.42 71.41 9.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 2.6 109.301 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -173.9 -77.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 3.74 109.526 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.57 129.07 1.38 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.462 -1.455 . . . . 1.99 109.462 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.079 HD21 ' CG ' ' A' ' 110' ' ' PHE . 76.0 mt -97.09 119.08 34.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 1.24 109.766 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.5 mt -88.28 166.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.76 108.855 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.575 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -142.43 103.41 4.25 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.294 -0.879 . . . . 1.36 109.426 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 22.7 mmtt -79.97 -169.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 1.55 109.574 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.575 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -90.64 133.59 35.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 2.67 109.733 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.38 -159.48 0.52 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.743 -1.343 . . . . 1.09 109.743 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.14 65.73 2.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.511 -1.436 . . . . 1.41 109.511 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG21 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -90.19 -1.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -1.164 . . . . 1.83 110.111 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.85 ' HB2' ' CB ' ' A' ' 25' ' ' ASN . . . -90.65 4.95 49.97 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.73 -0.606 . . . . 3.55 109.737 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -67.31 -73.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 4.72 109.323 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.451 ' O ' ' SD ' ' A' ' 125' ' ' MET . . . 41.94 27.23 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.694 -1.362 . . . . 5.2 109.694 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 126' ' ' LYS . 7.9 mmt -156.07 -69.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -1.149 . . . . 7.72 109.347 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 125' ' ' MET . 9.4 mmtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.029 -0.986 . . . . 10.07 109.463 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 21.9 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.482 -0.562 . . . . 1.65 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 14.6 pt-20 40.2 75.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.484 -0.76 . . . . 2.81 109.804 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.599 HD21 ' CB ' ' A' ' 83' ' ' GLN . 2.5 pt? -47.2 -36.8 9.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 1.75 109.561 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.525 ' N ' ' HG ' ' A' ' 3' ' ' LEU . 1.7 p -43.34 151.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 1.89 109.661 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 4' ' ' SER . 1.5 tttt 80.07 -72.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.601 -0.687 . . . . 2.54 109.75 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -86.76 17.06 4.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.075 -1.016 . . . . 4.04 109.638 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG12 ' CD2' ' A' ' 11' ' ' LEU . 11.9 t -151.51 -72.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 1.05 109.485 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.507 ' HB ' ' CD2' ' A' ' 87' ' ' TYR . 74.6 p -48.92 -23.24 1.04 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 1.93 109.462 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 10' ' ' LYS . . . -57.28 -54.41 37.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 2.51 109.555 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 9' ' ' GLY . 4.0 mtmt -145.54 62.71 1.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 3.24 109.455 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.853 ' CD2' HG12 ' A' ' 7' ' ' VAL . 11.2 mt -46.81 -61.49 1.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 1.65 109.495 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -158.67 126.1 4.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 3.51 109.479 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 12' ' ' ASP . 11.3 mttt -140.74 132.25 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 2.16 109.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 57' ' ' PHE . 38.2 p 48.89 57.8 6.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.422 -0.799 . . . . 3.15 109.562 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.4 m -170.02 105.78 0.44 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.466 -0.771 . . . . 2.28 109.325 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 117.65 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.367 2.045 . . . . 1.08 110.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 18' ' ' ILE . . . 170.02 -142.95 7.54 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.143 -1.583 . . . . 0.72 109.143 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.975 HD12 HD11 ' A' ' 47' ' ' LEU . 14.6 pt -157.27 141.83 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.151 -1.205 . . . . 0.98 110.115 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.573 ' O ' ' CZ3' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -121.51 111.17 16.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.854 -1.165 . . . . 2.7 107.854 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.898 HD11 ' HZ ' ' A' ' 110' ' ' PHE . 4.0 mt -88.87 177.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.941 -1.1 . . . . 0.61 110.052 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.693 ' H ' HG22 ' A' ' 20' ' ' ILE . 10.7 m-90 -137.84 117.93 13.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.151 -1.426 . . . . 0.36 107.151 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.676 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -78.47 134.78 37.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.143 -0.973 . . . . 2.33 110.185 -178.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.707 HD13 ' HA ' ' A' ' 28' ' ' MET . 10.9 mm -105.1 31.31 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.427 -0.953 . . . . 0.89 108.427 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HB2' HG12 ' A' ' 121' ' ' VAL . 2.4 pt-20 -57.44 166.01 1.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.526 -0.734 . . . . 2.63 109.879 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.85 ' CB ' ' HB2' ' A' ' 122' ' ' ALA . 14.4 p30 42.32 27.04 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.473 -0.767 . . . . 2.29 109.413 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.571 ' HE3' ' OE1' ' A' ' 73' ' ' GLU . 28.7 mmm 58.06 53.91 6.36 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.325 -0.859 . . . . 1.85 109.858 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 26' ' ' MET . 53.0 mt-10 -159.46 132.82 7.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.222 -0.924 . . . . 2.23 109.386 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.707 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -66.26 148.15 52.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 1.23 109.788 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG13 ' HD2' ' A' ' 30' ' ' PRO . 2.2 t -153.93 146.62 17.61 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.038 -1.097 . . . . 0.48 108.038 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HD2' HG13 ' A' ' 29' ' ' VAL . 31.5 Cg_endo -72.15 111.57 3.22 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.357 2.038 . . . . 0.87 112.03 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.676 HG23 ' H ' ' A' ' 22' ' ' ARG . 38.8 t -106.47 99.34 23.89 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.822 -0.807 . . . . 0.48 108.822 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 30' ' ' PRO . 35.3 Cg_endo -77.6 -159.57 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.501 2.134 . . . . 0.61 110.452 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -85.02 -8.73 58.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 1.21 109.104 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -74.2 -19.26 60.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.285 -0.884 . . . . 3.05 109.616 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -131.12 -5.59 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 1.4 110.185 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 33' ' ' THR . 0.2 OUTLIER -55.47 134.19 50.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 1.66 109.43 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 118.85 -69.88 0.33 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.414 -1.474 . . . . 1.04 109.414 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -83.17 83.7 7.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -1.163 . . . . 1.32 109.275 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.659 ' HZ ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -114.29 133.32 55.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 1.46 109.514 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.601 ' CD1' ' HB2' ' A' ' 117' ' ' LYS . 26.8 m-85 -39.21 147.85 0.06 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.563 -0.71 . . . . 1.55 110.15 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 20.1 pt-20 -90.33 -41.99 11.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.378 -0.826 . . . . 1.85 109.947 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.621 ' CA ' ' HB2' ' A' ' 68' ' ' ASN . . . -84.07 65.23 4.14 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 110.019 -1.232 . . . . 0.6 110.019 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' OD1' ' CB ' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -163.1 -145.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.052 -1.264 . . . . 1.35 110.374 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.525 ' CB ' HG13 ' A' ' 23' ' ' ILE . 7.4 m -142.03 146.32 35.39 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.247 -1.02 . . . . 0.37 108.247 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 39' ' ' PHE . 28.9 m-85 -144.63 109.9 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.941 -1.099 . . . . 1.28 110.285 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.565 HG13 ' OG1' ' A' ' 81' ' ' THR . 95.5 t -79.99 123.7 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.38 108.546 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.975 HD11 HD12 ' A' ' 18' ' ' ILE . 7.1 tt -112.15 118.44 35.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.75 110.347 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 59' ' ' TYR . 24.6 tp -102.81 106.76 17.42 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.124 -0.985 . . . . 0.45 109.616 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 18' ' ' ILE . 3.1 t -94.58 137.9 33.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.39 109.671 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 m -131.22 132.13 44.45 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.613 -0.679 . . . . 0.52 109.26 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.535 ' HG2' ' N ' ' A' ' 52' ' ' LYS . 35.8 ttm180 -125.43 160.03 30.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 2.73 109.458 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' N ' ' HG2' ' A' ' 51' ' ' ARG . 10.6 pttm -85.17 153.6 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.2 109.502 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -147.72 178.33 8.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 0.95 109.504 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.04 -17.55 74.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.516 -1.434 . . . . 1.06 109.516 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -98.66 -31.8 11.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -1.138 . . . . 1.39 109.502 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.38 -103.84 0.19 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.553 -1.419 . . . . 0.94 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 14' ' ' THR . 34.1 m-85 -141.4 153.44 45.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 1.56 109.521 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 m -117.42 109.66 17.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.38 -0.825 . . . . 1.06 108.915 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.699 ' HD1' HG23 ' A' ' 91' ' ' VAL . 32.4 m-85 -87.38 157.9 19.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 1.27 110.038 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' OD1' ' CG2' ' A' ' 93' ' ' VAL . 6.0 m-20 -148.29 91.18 1.88 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.376 -0.972 . . . . 0.94 108.376 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 1.005 ' CG2' HG23 ' A' ' 81' ' ' THR . 15.4 mt -78.17 135.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -0.908 . . . . 0.32 110.245 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 95' ' ' HIS . 48.6 m-70 -121.02 159.39 25.74 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.164 -0.68 . . . . 0.27 109.164 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 51.1 p90 -132.51 97.56 4.12 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.147 -1.421 . . . . 1.31 109.422 176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.609 ' CD1' ' HB3' ' A' ' 102' ' ' GLU . 4.9 t90 -76.99 132.86 39.22 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.879 -0.785 . . . . 0.47 108.879 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -120.53 65.43 0.84 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.368 -0.832 . . . . 0.7 110.976 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 41' ' ' GLU . . . -50.52 90.28 0.01 OUTLIER Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.215 -1.954 . . . . 0.33 108.215 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -38.74 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.094 0.95 . . . . 2.25 112.363 -177.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.621 ' HB2' ' CA ' ' A' ' 42' ' ' GLY . 1.6 m120 -162.76 -46.11 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.75 -0.833 . . . . 1.52 108.75 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 73' ' ' GLU . 80.8 p -60.87 -158.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.539 -0.726 . . . . 0.71 109.353 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.441 ' H ' ' HE1' ' A' ' 26' ' ' MET . 0.1 OUTLIER -111.92 166.7 10.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.95 109.609 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -47.98 -45.93 32.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.253 -0.904 . . . . 2.57 109.39 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -56.06 -41.1 74.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.882 . . . . 1.41 109.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE1' ' HE3' ' A' ' 26' ' ' MET . 13.0 tp10 -55.28 -40.86 71.52 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.275 -1.009 . . . . 2.37 108.275 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.435 ' HG3' HD11 ' A' ' 65' ' ' LEU . 4.9 tt0 -59.54 -36.52 76.3 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.979 -1.119 . . . . 2.35 107.979 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -70.83 -25.5 75.65 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.005 -1.638 . . . . 0.47 109.005 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -74.89 -66.0 0.8 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -1.115 . . . . 0.47 109.326 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . . . -46.11 -37.27 6.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.36 109.359 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.58 -38.19 67.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.4 109.588 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 75' ' ' GLY . 16.1 mt -61.19 -50.33 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.973 . . . . 1.4 109.553 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 92.5 m-85 -57.37 -44.22 84.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.069 -1.019 . . . . 1.48 108.915 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.005 HG23 ' CG2' ' A' ' 61' ' ' ILE . 3.6 m -64.36 -24.9 67.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.4 108.677 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -83.98 -20.39 32.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.542 -0.724 . . . . 0.47 109.254 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.599 ' CB ' HD21 ' A' ' 3' ' ' LEU . 10.3 mt-30 -84.95 -32.29 23.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 1.75 109.527 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.79 ' HG3' HD13 ' A' ' 61' ' ' ILE . 14.6 ptp -86.89 -18.72 30.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 1.23 109.394 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.568 ' HA ' HD11 ' A' ' 61' ' ' ILE . 25.9 t0 -67.89 -40.06 83.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.875 . . . . 1.32 109.372 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -89.92 -37.17 14.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 2.21 109.421 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.507 ' CD2' ' HB ' ' A' ' 8' ' ' THR . 6.2 m-85 -67.18 -17.26 64.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.875 . . . . 1.67 109.45 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' CD1' ' A' ' 11' ' ' LEU . 15.4 mt -81.38 -24.16 37.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.83 109.492 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' SER . . . 123.93 7.68 6.51 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.653 -1.379 . . . . 0.66 109.653 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' GLY . 0.1 OUTLIER 76.06 -0.69 3.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -1.154 . . . . 2.25 109.646 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.699 HG23 ' HD1' ' A' ' 59' ' ' TYR . 27.4 m -83.67 -12.78 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 1.28 109.331 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 59' ' ' TYR . . . -78.09 173.54 12.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.326 -0.859 . . . . 0.4 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 94' ' ' GLN . 3.8 t -128.41 176.52 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.388 -0.82 . . . . 0.36 109.139 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.674 ' H ' HG12 ' A' ' 93' ' ' VAL . 14.5 tt0 -123.88 133.25 53.79 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.022 -1.049 . . . . 2.16 109.219 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' TYR . 23.0 m-70 -128.41 152.22 48.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.27 109.508 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 43.7 ttt180 -110.22 131.69 54.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.43 110.354 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' C ' ' CG2' ' A' ' 98' ' ' VAL . 29.2 mm-40 -141.92 163.93 31.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 2.01 109.42 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 99' ' ' GLN . 2.2 t -154.74 -164.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.45 108.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.752 ' H ' HG12 ' A' ' 98' ' ' VAL . 15.3 pt20 -75.95 2.65 12.0 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.736 -1.227 . . . . 2.34 109.965 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.12 19.96 0.96 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.252 -1.939 . . . . 0.73 108.252 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.542 ' HB2' ' N ' ' A' ' 98' ' ' VAL . 10.7 m-70 -122.06 -19.47 6.6 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.658 -0.907 . . . . 0.99 109.486 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 64' ' ' TRP . 0.0 OUTLIER -90.21 24.36 2.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 2.77 109.168 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 102' ' ' GLU . 6.0 p -47.63 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.366 -0.834 . . . . 1.45 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.871 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 20.7 mt-10 -68.15 -17.48 64.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.98 -1.075 . . . . 2.24 111.276 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.475 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m -72.85 -55.31 6.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.817 -1.177 . . . . 0.63 109.628 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.554 ' HB2' ' CB ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -63.02 -56.03 20.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.26 -1.015 . . . . 1.25 108.26 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' PHE . 10.7 ttp85 -57.98 -29.63 65.4 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.312 -0.867 . . . . 1.95 108.79 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 104' ' ' GLU . . . -53.32 -53.39 51.64 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.171 -1.048 . . . . 0.69 108.171 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.579 ' HB3' HD13 ' A' ' 18' ' ' ILE . 28.1 m-85 -64.75 -23.48 67.26 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.643 -0.873 . . . . 1.21 108.643 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 1.079 ' CG ' HD21 ' A' ' 114' ' ' LEU . 14.8 m-85 -107.59 94.94 5.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.473 -0.767 . . . . 1.4 109.463 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -82.42 71.41 9.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 2.6 109.301 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -173.9 -77.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 3.74 109.526 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.57 129.07 1.38 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.462 -1.455 . . . . 1.99 109.462 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.079 HD21 ' CG ' ' A' ' 110' ' ' PHE . 76.0 mt -97.09 119.08 34.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 1.24 109.766 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 116' ' ' TYR . 2.5 mt -88.28 166.98 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.76 108.855 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.575 ' N ' ' CG2' ' A' ' 115' ' ' ILE . 0.9 OUTLIER -142.43 103.41 4.25 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.294 -0.879 . . . . 1.36 109.426 179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 40' ' ' TYR . 22.7 mmtt -79.97 -169.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 1.55 109.574 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.575 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -90.64 133.59 35.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 2.67 109.733 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.38 -159.48 0.52 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.743 -1.343 . . . . 1.09 109.743 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 48.14 65.73 2.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.511 -1.436 . . . . 1.41 109.511 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.599 HG21 ' OH ' ' A' ' 40' ' ' TYR . 2.2 p -90.19 -1.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -1.164 . . . . 1.83 110.111 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.85 ' HB2' ' CB ' ' A' ' 25' ' ' ASN . . . -90.65 4.95 49.97 Favored 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.73 -0.606 . . . . 3.55 109.737 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -67.31 -73.58 0.13 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.131 -0.981 . . . . 4.72 109.323 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.451 ' O ' ' SD ' ' A' ' 125' ' ' MET . . . 41.94 27.23 0.36 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.694 -1.362 . . . . 5.2 109.694 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 126' ' ' LYS . 7.9 mmt -156.07 -69.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -1.149 . . . . 7.72 109.347 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 125' ' ' MET . 9.4 mmtm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.029 -0.986 . . . . 10.07 109.463 -179.988 . . . . . . . . 1 1 . 1 stop_ save_